Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene
© Sukka-Ganesh et al.; licensee BioMed Central Ltd. 2012
Received: 28 December 2011
Accepted: 28 June 2012
Published: 23 July 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|28 Dec 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|26 Jan 2012||Reviewed||Reviewer Report - Christine Sers|
|6 Feb 2012||Reviewed||Reviewer Report - Tyson Sharp|
|9 Feb 2012||Reviewed||Reviewer Report - Tommaso Dragani|
|29 Mar 2012||Author responded||Author comments - Najmunnisa Nasreen|
|Resubmission - Version 3|
|29 Mar 2012||Submitted||Manuscript version 3|
|18 Apr 2012||Reviewed||Reviewer Report - Christine Sers|
|11 Jun 2012||Author responded||Author comments - Najmunnisa Nasreen|
|Resubmission - Version 4|
|11 Jun 2012||Submitted||Manuscript version 4|
|18 Jun 2012||Author responded||Author comments - Najmunnisa Nasreen|
|Resubmission - Version 5|
|18 Jun 2012||Submitted||Manuscript version 5|
|28 Jun 2012||Editorially accepted|
|23 Jul 2012||Article published||10.1186/1471-2407-12-309|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.